{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T00:35:22Z","timestamp":1708734922894},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,4]]},"DOI":"10.7759\/cureus.41344","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T12:07:10Z","timestamp":1708690030000},"source":"Crossref","is-referenced-by-count":0,"title":["DICER1 Syndrome in Twins With Ovarian Sertoli-Leydig Cell Tumor and Papillary Thyroid Carcinoma"],"prefix":"10.7759","author":[{"given":"Hessah A","family":"Al Hussaini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maswood M","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majed","family":"Albarrak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suphia M","family":"Sherbeeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"AlHuzaim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-3089","article-title":"DICER1 and associated conditions: identification of at-risk individuals and recommended surveillance strategies","volume":"24","author":"Schultz KA","year":"2018","unstructured":"Schultz KA, Williams GM, Kamihara J, et al.. DICER1 and associated conditions: identification of at-risk individuals and recommended surveillance strategies. Clin Cancer Res. 2018, 24:2251-61. 10.1158\/1078-0432.CCR-17-3089","journal-title":"Clin Cancer Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.555","article-title":"The prevalence of germline DICER1 pathogenic variation in cancer populations","volume":"7","author":"Kim J","year":"2019","unstructured":"Kim J, Schultz KA, Hill DA, Stewart DR. The prevalence of germline DICER1 pathogenic variation in cancer populations. Mol Genet Genomic Med. 2019, 7:10.1002\/mgg3.555","journal-title":"Mol Genet Genomic Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/hed.23250","article-title":"Novel DICER1 mutation as cause of multinodular goiter in children","volume":"35","author":"Darrat I","year":"2013","unstructured":"Darrat I, Bedoyan JK, Chen M, Schuette JL, Lesperance MM. Novel DICER1 mutation as cause of multinodular goiter in children. Head Neck. 2013, 35:369-71. 10.1002\/hed.23250","journal-title":"Head Neck"},{"key":"ref4","article-title":"DICER1 tumor predisposition","author":"Schultz KA","year":"2014","unstructured":"Schultz KA. DICER1 tumor predisposition. GeneReviews\u00ae [Internet]. Adam MP (ed): University of Washington, Seattle, WA; 2014."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-17-0509","article-title":"DICER1 gene mutations in endocrine tumors","volume":"25","author":"Solarski M","year":"2018","unstructured":"Solarski M, Rotondo F, Foulkes WD, et al.. DICER1 gene mutations in endocrine tumors. Endocr Relat Cancer. 2018, 25:197-208. 10.1530\/ERC-17-0509","journal-title":"Endocr Relat Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2954","article-title":"Quantification of thyroid cancer and multinodular goiter risk in the DICER1 syndrome: a family-based cohort study","volume":"102","author":"Khan NE","year":"2017","unstructured":"Khan NE, Bauer AJ, Schultz KA, et al.. Quantification of thyroid cancer and multinodular goiter risk in the DICER1 syndrome: a family-based cohort study. J Clin Endocrinol Metab. 2017, 102:1614-22. 10.1210\/jc.2016-2954","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3747\/co.26.4727","article-title":"A family with Sertoli-Leydig cell tumour, multinodular goiter, and DICER1 mutation","volume":"26","author":"Haley M","year":"2019","unstructured":"Haley M, Bindal P, McAuliffe A, Vredenburgh J. A family with Sertoli-Leydig cell tumour, multinodular goiter, and DICER1 mutation. Curr Oncol. 2019, 26:183-5. 10.3747\/co.26.4727","journal-title":"Curr Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel DP","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004, 116:281-97. 10.1016\/s0092-8674(04)00045-5","journal-title":"Cell"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/ng2003","article-title":"Impaired microRNA processing enhances cellular transformation and tumorigenesis","volume":"39","author":"Kumar MS","year":"2007","unstructured":"Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet. 2007, 39:673-7. 10.1038\/ng2003","journal-title":"Nat Genet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1910","article-title":"DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors","volume":"305","author":"Rio Frio T","year":"2011","unstructured":"Rio Frio T, Bahubeshi A, Kanellopoulou C, et al.. DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors. JAMA. 2011, 305:68-77. 10.1001\/jama.2010.1910","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.6746.2","article-title":"Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in pleuropulmonary blastoma\/DICER1 syndrome: a unique variant of the two-hit tumor suppression model","volume":"4","author":"Brenneman M","year":"2015","unstructured":"Brenneman M, Field A, Yang J, et al.. Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in pleuropulmonary blastoma\/DICER1 syndrome: a unique variant of the two-hit tumor suppression model. F1000Res. 2015, 4:10.12688\/f1000research.6746.2","journal-title":"F1000Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/path.4135","article-title":"Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage","volume":"229","author":"Anglesio MS","year":"2013","unstructured":"Anglesio MS, Wang Y, Yang W, et al.. Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage. J Pathol. 2013, 229:400-9. 10.1002\/path.4135","journal-title":"J Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7927362","article-title":"Sertoli-Leydig cell tumour and DICER1 mutation: a case report and review of the literature","volume":"2018","author":"Wormald B","year":"2018","unstructured":"Wormald B, Elorbany S, Hanson H, Williams JW, Heenan S, Barton DP. Sertoli-Leydig cell tumour and DICER1 mutation: a case report and review of the literature. Case Rep Obstet Gynecol. 2018, 2018:10.1155\/2018\/7927362","journal-title":"Case Rep Obstet Gynecol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00774","article-title":"Clinical and molecular characteristics may alter treatment strategies of thyroid malignancies in DICER1 syndrome","volume":"104","author":"Van der Tuin K","year":"2019","unstructured":"Van der Tuin K, de Kock L, Kamping EJ, et al.. Clinical and molecular characteristics may alter treatment strategies of thyroid malignancies in DICER1 syndrome. J Clin Endocrinol Metab. 2019, 104:277-84. 10.1210\/jc.2018-00774","journal-title":"J Clin Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10050143","article-title":"DICER1 syndrome: DICER1 mutations in rare cancers","volume":"10","author":"Robertson JC","year":"2018","unstructured":"Robertson JC, Jorcyk CL, Oxford JT. DICER1 syndrome: DICER1 mutations in rare cancers. Cancers (Basel). 2018, 10:10.3390\/cancers10050143","journal-title":"Cancers (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2169","article-title":"DICER1 mutations and differentiated thyroid carcinoma: evidence of a direct association","volume":"101","author":"Rutter MM","year":"2016","unstructured":"Rutter MM, Jha P, Schultz KA, et al.. DICER1 mutations and differentiated thyroid carcinoma: evidence of a direct association. J Clin Endocrinol Metab. 2016, 101:1-5. 10.1210\/jc.2015-2169","journal-title":"J Clin Endocrinol Metab"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-021-00264-y","article-title":"Surveillance recommendations for DICER1 pathogenic variant carriers: a report from the SIOPE Host Genome Working Group and CanGene-CanVar Clinical Guideline Working Group","volume":"20","author":"Bakhuizen JJ","year":"2021","unstructured":"Bakhuizen JJ, Hanson H, van der Tuin K, Lalloo F, Tischkowitz M, Wadt K, Jongmans MC. Surveillance recommendations for DICER1 pathogenic variant carriers: a report from the SIOPE Host Genome Working Group and CanGene-CanVar Clinical Guideline Working Group. Fam Cancer. 2021, 20:337-48. 10.1007\/s10689-021-00264-y","journal-title":"Fam Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/158824-dicer1-syndrome-in-twins-with-ovarian-sertoli-leydig-cell-tumor-and-papillary-thyroid-carcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T12:07:12Z","timestamp":1708690032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/158824-dicer1-syndrome-in-twins-with-ovarian-sertoli-leydig-cell-tumor-and-papillary-thyroid-carcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,4]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.41344","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,4]]}}}